Low-dose aspirin for the prevention of atherothrombosis

C Patrono, LA García Rodríguez… - … England Journal of …, 2005 - Mass Medical Soc
This review considers the role of low-dose aspirin for the prevention of atherothrombosis,
discussing the molecular mechanism of action of aspirin as well as clinical and …

Expert consensus document on the use of antiplatelet agents: The Task Force on the Use of Antiplatelet Agents in Patients With Atherosclerotic Cardiovascular …

C Patrono, F Bachmann, C Baigent, C Bode… - European heart …, 2004 - academic.oup.com
The role of aspirin and other platelet-active drugs in the treatment and prevention of
atherothrombosis has been reviewed recently by the Sixth American College of Chest …

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

JW Eikelboom, J Hirsh, JI Weitz, M Johnston, Q Yi… - Circulation, 2002 - Am Heart Assoc
Background—We studied whether aspirin resistance, defined as failure of suppression of
thromboxane generation, increases the risk of cardiovascular events in a high-risk …

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

PA Gum, K Kottke-Marchant, PA Welsh, J White… - Journal of the American …, 2003 - jacc.org
Objectives: This study was designed to determine if aspirin resistance is associated with
clinical events. Background: Aspirin resistance, defined by platelet function testing and …

Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

C Patrono, B Coller, GA FitzGerald, J Hirsh, G Roth - Chest, 2004 - Elsevier
This article discusses platelet active drugs as part of the Seventh American College of Chest
Physicians Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based …

Platelet-active drugs: the relationships among dose, effectiveness, and side effects

C Patrono, B Coller, JE Dalen, GAF Gerald, V Fuster… - Chest, 2001 - journal.chestnet.org
Abbreviations: ACE trial Acetylsalicylic Acid and Carotid Endarterectomy; ADP adenosine
diphosphate; AMP adenosine monophosphate; CAPRIE study Clopidogrel vs Aspirin in …

Overexpression of Functionally Coupled Cyclooxygenase-2 and Prostaglandin E Synthase in Symptomatic Atherosclerotic Plaques as a Basis of Prostaglandin E2 …

F Cipollone, C Prontera, B Pini, M Marini, M Fazia… - Circulation, 2001 - Am Heart Assoc
Background—Studies have implicated a role for prostaglandin (PG) E2-dependent matrix
metalloproteinase (MMP) biosynthesis in the rupture of atherosclerotic plaque …

Cyclooxygenase-1 and-2–dependent prostacyclin formation in patients with atherosclerosis

O Belton, D Byrne, D Kearney, A Leahy, DJ Fitzgerald - Circulation, 2000 - Am Heart Assoc
Background—The formation of prostacyclin (PGI2), thromboxane (TX) A2, and isoprostanes
is markedly enhanced in atherosclerosis. We examined the relative contribution of …

Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers

D Cox, AO Maree, M Dooley, R Conroy, MF Byrne… - Stroke, 2006 - Am Heart Assoc
Background and Purpose—Aspirin resistance may be relatively common and associated
with adverse outcome. Meta-analysis has clearly shown that 75 mg plain aspirin is the …

Effectiveness and tolerance of anti‐inflammatory drugs' add‐on therapy in major mental disorders: a systematic qualitative review

G Fond, N Hamdani, F Kapczinski… - Acta Psychiatrica …, 2014 - Wiley Online Library
Objective To provide a systematic review of the literature regarding the efficacy of anti‐
inflammatory drugs in three major mental disorders [major depressive disorder (MDD) …